Median Technologies reports on its 2021 half-year results and its Q3 2021 business activity indicators 日期：2021/11/08 来自：Median Technologies 了解详情

Median Technologies has been confirmed as a preferred vendor by one of the Top 3 pharmaceutical companies in the world, and selected to implement their clinical trial imaging strategy on some key oncology indications 日期：2021/11/08 来自：Median Technologies 了解详情

Median Technologies announces outstanding performance for its iBiopsy® Lung Cancer Screening CADx to accurately characterize malignant vs benign lung nodules based on a large-scale patient cohort 日期：2021/11/08 来自：Median Technologies 了解详情